obesity drug news today glp-1 The next phase of the race Commentary: New obesity drugs face

The peptide's action stimulates the work of macrophages and fibroblasts, leading to faster elimination of inflammation and wound healing by releasing growth factors that promote further migration and proliferation of fibroblasts

Reduced acetylcholine receptors and increased acetylcholinesterase activity in AD cause hyperphosphorylation of Tau protein, reduced secretion of soluble amyloid precursor protein (APP) and increased synthesis of A

Muscle symptoms accompanied by other concerning features require more urgent evaluation

10.1038/ajg.2011.315 Am J Gastroenterol

DOI:10.1111/j.1600-0676.1992.tb00583.x [ Links ] 73

What to watch for: Stay topicalsystemic copper metabolism can get tricky